Establishing a solid digital presence ensures your business can be found, trusted and remembered. That means having a clear ...
MannKind has made the decision to discontinue the ICoN-1 Phase 3 clinical trial evaluating nebulized clofazimine inhalation suspension for nontuberculous mycobacterial (NTM) lung disease, following a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback